Status:
COMPLETED
An Investigational Drug in Patients With Osteoarthritis (0663-073)
Lead Sponsor:
Organon and Co
Conditions:
Osteoarthritis
Eligibility:
All Genders
40+ years
Phase:
PHASE3
Brief Summary
This study was conducted to assess the safety and tolerability of an investigational drug and to evaluate its effectiveness in the treatment of osteoarthritis of the hip or knee in both men and women.
Detailed Description
The duration of treatment is 12 weeks.
Eligibility Criteria
Inclusion
- Patients with osteoarthritis of the hip or knee who use current approved medication (nonsteroidal anti-inflammatory drugs (NSAIDs)) or tylenol to treat the symptoms of their osteoarthritis. Patients taking NSAIDs are required to discontinue using these drugs and their symptoms must become worse.
Exclusion
- Patients with certain medical conditions may not be allowed to participate. These conditions will be reviewed with the study physician.
Key Trial Info
Start Date :
April 9 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 13 2003
Estimated Enrollment :
548 Patients enrolled
Trial Details
Trial ID
NCT00092755
Start Date
April 9 2003
End Date
November 13 2003
Last Update
August 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.